Reynolds GP - Search Results

1

Metabolic Effects of 7 Antipsychotics on Patients With Schizophrenia: A Short-Term, Randomized, Open-Label, Multicenter, Pharmacologic Trial.

Zhang Y, Wang Q, Reynolds GP, Yue W, Deng W, Yan H, Tan L, Wang C, Yang G, Lu T, Wang L, Zhang F, Yang J, Li K, Lv L, Tan Q, Li Y, Yu H, Zhang H, Ma X, Yang F, Li L, Chen Q, Wei W, Zhao L, Wang H, Li X, Guo W, Hu X, Tian Y, Ren H, Ma X, Coid J, Zhang D, Li T; Chinese Antipsychotics Pharmacogenomics Consortium. Zhang Y, et al. Among authors: reynolds gp. J Clin Psychiatry. 2020 Mar 24;81(3):19m12785. doi: 10.4088/JCP.19m12785. J Clin Psychiatry. 2020. PMID: 32237292 Clinical Trial.

2

Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain.

Reynolds GP, Zhang Z, Zhang X. Reynolds GP, et al. Am J Psychiatry. 2003 Apr;160(4):677-9. doi: 10.1176/appi.ajp.160.4.677. Am J Psychiatry. 2003. PMID: 12668355

3

Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia.

Zhang ZJ, Yao ZJ, Liu W, Fang Q, Reynolds GP. Zhang ZJ, et al. Among authors: reynolds gp. Br J Psychiatry. 2004 Jan;184:58-62. doi: 10.1192/bjp.184.1.58. Br J Psychiatry. 2004. PMID: 14702228

4

Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia.

Yevtushenko OO, Cooper SJ, O'Neill R, Doherty JK, Woodside JV, Reynolds GP. Yevtushenko OO, et al. Among authors: reynolds gp. Br J Psychiatry. 2008 Jun;192(6):424-8. doi: 10.1192/bjp.bp.107.041723. Br J Psychiatry. 2008. PMID: 18515891

5

The Etiology of Metabolic Disturbances in Schizophrenia: Drugs, Genes, and Environment.

Reynolds GP. Reynolds GP. Int J Neuropsychopharmacol. 2021 Oct 23;24(10):854-855. doi: 10.1093/ijnp/pyab047. Int J Neuropsychopharmacol. 2021. PMID: 34252192 Free PMC article. No abstract available.

6

Developments in the drug treatment of schizophrenia.

Reynolds GP. Reynolds GP. Trends Pharmacol Sci. 1992 Mar;13(3):116-21. doi: 10.1016/0165-6147(92)90041-4. Trends Pharmacol Sci. 1992. PMID: 1349447 Review.

7

New approaches to the drug treatment of schizophrenia.

Reynolds GP, Czudek C. Reynolds GP, et al. Adv Pharmacol. 1995;32:461-503. doi: 10.1016/s1054-3589(08)61020-0. Adv Pharmacol. 1995. PMID: 7748802 Review. No abstract available.

8

Antipsychotic drug mechanisms and neurotransmitter systems in schizophrenia.

Reynolds GP. Reynolds GP. Acta Psychiatr Scand Suppl. 1994;380:36-40. doi: 10.1111/j.1600-0447.1994.tb05830.x. Acta Psychiatr Scand Suppl. 1994. PMID: 7914046 Review.

9

Dopamine receptors and schizophrenia.

Reynolds GP. Reynolds GP. Biochem Soc Trans. 1996 Feb;24(1):202-5. Biochem Soc Trans. 1996. PMID: 8674664 Review. No abstract available.

10

Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins.

Beasley CL, Zhang ZJ, Patten I, Reynolds GP. Beasley CL, et al. Among authors: reynolds gp. Biol Psychiatry. 2002 Oct 1;52(7):708-15. doi: 10.1016/s0006-3223(02)01360-4. Biol Psychiatry. 2002. PMID: 12372661

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

315 results

Search Page

Filters